Meet PharmaTech-LLC @ the 2016 Annual GPhA in Sunny Orlando!

Meet PharmaTech-LLC @ the 2016 Annual GPhA in Sunny Orlando!

images

GPhA 2016 Annual Meeting has nearly 700 attendees who gather to gain insight on how the nation’s most critical health and regulatory issues will impact the generic industry and the consumers who benefit from access to affordable medicines.

The meeting attracts leading speakers from around the globe who will leave attendees with a comprehensive understanding of the opportunities and challenges for the generic pharmaceutical sector in 2016. This lineup combined with unparalleled networking opportunities makes GPhA’s Annual Meeting the generic industry event of the year, which is why PharmaTech-LLC is excited to announce our participation as an exhibitor.

You can find us located at booth #26!!

Can’t Wait To See You There!

Schedule a meeting to expand your knowledge of the services PharmaTech can offer you by contacting Tammy Fechner @ tfechner@pharmatech-llc.com

To learn more about PharmaTech-LLC, visit out website @ www.pharmatech-llc.com

To find our more information about GPhA Orlando, visit http://www.gphaonline.org/events/upcoming-events/2016-annual-meeting

Share
Meet Us At Arab Health 2016!

Meet Us At Arab Health 2016!

January 25-28, 2016 Dubai International Convention & Exhibition Centre Arab Health Exhibition & Congress, organized by Informa Life Sciences Exhibitions, began 41 years ago as a small trade show under canvas on a patch of land in Dubai, United Arab Emirates. As Dubai and the UAE developed and grew, so did the need for healthcare… Continue Reading

Share
PharmaTech LLC Announces South Florida Facility Expansion

PharmaTech LLC Announces South Florida Facility Expansion

November 23, 2015 Davie, FL – Privately owned Contract Development and Manufacturing Organization (CDMO) PharmaTech LLC has announced that it has undertaken significant expansion of its current state of the art research, development and manufacturing facility outside of Fort Lauderdale, Florida. The investment is part of PharmaTech’s strategy to increase its manufacturing capacity as well… Continue Reading

Share
Beware: Inferior OTC Generics Manufactured Abroad

Beware: Inferior OTC Generics Manufactured Abroad

Many pharmaceutical companies have started to outsource the production of generic drugs to foreign countries, such as India and China. Some online pharmacies offer both generic and branded drugs from overseas sources because it costs less to produce a drug in another country. That lower cost can come at a price, however. While the incidents… Continue Reading

Share
Quality Assurance of Overseas Manufacturer’s Is Shaky at Best

Quality Assurance of Overseas Manufacturer’s Is Shaky at Best

Reasons to Domestically Outsource OTC Generic Manufacturing The manufacture of generic drugs, like so many other products that Americans consume, is being outsourced to facilities overseas where labor and other costs are lower than inside the United States. Many of the generic medications that Americans take for what ails them are made in China or… Continue Reading

Share
David Greeley Joins Pharmatech Executive Team

David Greeley Joins Pharmatech Executive Team

“We are pleased to have David Greeley join PharmaTech LLC as Chief Operations Officer,” said Ray Figueroa, President and CEO of PharmaTech LLC. “David is uniquely qualified to lead the daily operations at PharmaTech LLC because he has a thorough understanding of our industry and how to implement innovative ideas to support our clients.” Mr.… Continue Reading

Share
Pharmatech Expands Liquid Dose Production Capacity

Pharmatech Expands Liquid Dose Production Capacity

PharmaTech LLC. of Davie, FL invests in the future by recently completing expansion of its liquid dose manufacturing capacity. In the midst of a record sales year, PharmaTech expanded from one (1) liquid dose line to THREE (3) fully automated liquid lines. Two (2) additional mixing tanks were also added to the production line in order… Continue Reading

Share
First to File ANDA and Command an OTC Generic Drugs Market

First to File ANDA and Command an OTC Generic Drugs Market

The Abbreviated New Drug Application or ANDA, established in 1984 by the Hatch-Waxman Act, allows OTC (Over-the-Counter) generic drug companies to conduct testing prior to a branded drug’s patent expiration date. This creates an opportunity for OTC generic drug manufacturers to chip away at a branded drug’s market share. A successfully submitted ANDA allows OTC… Continue Reading

Share
3 Key Ingredients to Custom Vitamin Formulation Development

3 Key Ingredients to Custom Vitamin Formulation Development

The development of Custom Vitamin Formulations has become more and more popular in recent years. This trend is powered by a growing population with a desire to live longer coupled with a healthier lifestyle. The U.S. vitamin and supplement market is estimated to become a $28 billion dollar a year juggernaut by the year 2016. In spite the fact that… Continue Reading

Share
Outsourcing Generic Formulation Development Can Improve Your Bottom Line

Outsourcing Generic Formulation Development Can Improve Your Bottom Line

Demand for outsourcing pharmaceutical formulation development and manufacturing is on the rise for drug developers at all levels. The significant number of new innovator drug patents coupled with exclusivity protections expiring or expired has resulted in many products and product categories with limited or no generic competition. This unique combination of events has created significant… Continue Reading

Share